Safety and Efficacy of Low Temperature Contrast in UAP Patients During PCI (LOTA-I) (LOTA-I)
Safety and Efficacy of Low Temperature Contrast for the Treatment of PCI-related Myocardial Injury in Patients With Unstable Angina Pectoris (LOTA-I)
Sponsor: Nanjing First Hospital, Nanjing Medical University
A NA clinical study on Unstable Angina Pectoris, this trial is completed. The trial is conducted by Nanjing First Hospital, Nanjing Medical University and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2022 — Dec 2023 [monthly]
Recruiting NA
-
Oct 2021 — May 2022 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2019 — Jun 2020 [monthly]
Recruiting NA
-
Nov 2018 — Nov 2019 [monthly]
Recruiting NA
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nanjing First Hospital, Nanjing Medical University
For direct contact, visit the study record on ClinicalTrials.gov .